Skip to content

Quantra QPlus Sample Type Comparison

Impact of Sample Type and Assay Time on the Performance of the Quantra QPlus System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05290675
Enrollment
50
Registered
2022-03-22
Start date
2021-11-04
Completion date
2022-11-02
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation Defect; Bleeding

Keywords

Cardiac surgery, Quantra, Viscoelastic testing, Coagulation

Brief summary

This is a single center prospective observational study to compare QPlus parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing cardiac surgery.

Detailed description

In this single center prospective observational study, 40 cardiac surgery subjects will enrolled, each with parallel artrial and venous samples collected at 3 time points to yield 120 matched samples for analysis on the Quantra System with the QPlus Cartridge.

Interventions

DIAGNOSTIC_TESTQuantra QPlus System

Whole blood coagulation testing system

Sponsors

HemoSonics LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is scheduled for cardiac surgery, utilizing cardiopulmonary bypass, or including placement of a ventricular assist device * Subject is ≥18 years * Subject or subject's legally authorized representative is willing to participate and he/she has signed a consent formr.

Exclusion criteria

* Subject is younger than 18 years * Subject is pregnant * Subject is incarcerated at the time of the study * Subject is affected by a condition that, in the opinion of the surgical team, may pose additional risks * Subject, or subject's legally aurthorized representative is able to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Comparison of QPlus Clot time (CT) in arterial and venous samplesDuring cardiac surgeryCoagulation function assessed in two sample types
Comparison of QPlus Clot time with Heparinase (CTH) in arterial and venous samplesDuring cardiac surgeryCoagulation function assessed in two sample types
Comparison of Clot stiffness (CS) determined with Quantra QPlus Cartridge in arterial and venous samplesDuring cardiac surgeryMeasure of the overall shear modulus or strength/quality of the clot determined using SEER sonorheometry assessed in two sample types
Comparison of QPlus Platelet Contribution to Clot stiffness (PCS) in arterial and venous samplesDuring cardiac surgeryMeasure of the shear modulus or strength/quality of the clot contributed by platelets determined using SEER sonorheometry assessed in two sample types
Comparison of QPlus Fibrinogen Contribution to Clot stiffness (FCS) in arterial and venous samplesDuring cardiac surgeryMeasure of the shear modulus or strength/quality of the clot contributed by fibrinogen determined using SEER sonorheometry assessed in two sample types

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026